COVID-19 Phase 3 Assess Efficacy of Ruxolitinib

Clinical Trial Grant

Duke Scholars

Principal Investigator Lindsay Anne Magura Rein Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

Incyte Corporation

Start Date

May 1, 2020

End Date

December 28, 2021

Awarded By

Incyte Corporation

Start Date

May 1, 2020

End Date

December 28, 2021